LGD-4033 Ligandrol Oral Steroids Tablets 10mg 100pcs

Description

LGD-4033 Ligandrol SARM Muscle Growth Research

Pharmacodynamics

The biochemical activity of LGD-4033 is defined by its ability to act as a potent ligand for the nuclear androgen receptor. At the molecular level, the molecule enters the target cell and agonizes the receptor with high specificity, avoiding the cross-reactivity associated with non-selective androgens. This defines the first semantic triple: [LGD-4033 agonizes skeletal muscle AR]. Following this, the ligand-receptor complex translocates to the nucleus to initiate a conformational change in gene expression patterns. This establishes the second triple: [Binding induces conformational gene shifts]. Furthermore, this genomic activation upregulates the transcription of structural proteins involved in myofibrillar growth. This forms the third triple: [AR activation promotes myofibrillar transcription]. Quantitatively, LGD-4033 possesses a systemic half-life of approximately 24 to 36 hours ($t_{1/2}=30pm6$h) in research models, providing a stable model for consistent receptor occupancy. In comparative studies, LGD-4033 is distinguished from MK-2866 (Ostarine) by its significantly higher anabolic-to-androgenic ratio and superior potency per milligram in stimulating lean tissue accrual.

Molecular Data

• CAS Number: 1165910-22-4
• Molecular Formula: C14H12F6N2O
• Molecular Weight: 338.25 g/mol
• Purity: >99.0% via HPLC-UV
• Appearance: Fine white to off-white crystalline powder

Research Observations

• Accelerated Lean Mass Accrual: Users in research models report significant increases in skeletal muscle density within short experimental durations.
• Enhanced Strength Output: Published research indicates marked improvements in maximum force production during intense mechanical loading.
• Bone Mineralization Support: Based on community feedback, research models show potential efficacy in improving bone density and skeletal integrity.
• Optimized Nutrient Partitioning: Aggregated data shows a shift in caloric direction toward lean tissue maintenance rather than adipose storage.
• Vascular Resilience: Research models have observed improved muscle fullness and localized blood flow during exertion phases.

About This Compound

LGD-4033, also known as Ligandrol, is a non-steroidal, tissue-selective androgen receptor modulator (SARM) characterized by its high affinity for the androgen receptor in skeletal muscle and bone tissues. [LGD-4033 binds to tissue-selective androgen receptors]. This signaling molecule serves as a primary research benchmark for investigating the prevention of muscle wasting and the molecular triggers of sarcopenia reversal. Unlike traditional anabolic steroids, it is specifically engineered to minimize androgenic activity in sebaceous glands and the prostate.
Summary:
LGD-4033 represents a premier research tool for investigating the selective modulation of androgen signaling and the molecular control of skeletal muscle hypertrophy.

Frequently Asked Questions

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare professional before use.